Specifically, AMG 701 holds an extended half-life in vivo and mediates T-cell dependent cellular cytotoxicity (TDCC) of BCMA positive MM cells and is currently under clinical investigation (NCT03287908). The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.